We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Is Bausch Health Cos (BHC) Stock Outpacing Its Medical Peers This Year?
Read MoreHide Full Article
The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Is Bausch Health Cos (BHC - Free Report) one of those stocks right now? By taking a look at the stock's year-to-date performance in comparison to its Medical peers, we might be able to answer that question.
Bausch Health Cos is one of 844 companies in the Medical group. The Medical group currently sits at #3 within the Zacks Sector Rank. The Zacks Sector Rank considers 16 different groups, measuring the average Zacks Rank of the individual stocks within the sector to gauge the strength of each group.
The Zacks Rank is a successful stock-picking model that emphasizes earnings estimates and estimate revisions. The system highlights a number of different stocks that could be poised to outperform the broader market over the next one to three months. BHC is currently sporting a Zacks Rank of #2 (Buy).
Over the past three months, the Zacks Consensus Estimate for BHC's full-year earnings has moved 8.18% higher. This shows that analyst sentiment has improved and the company's earnings outlook is stronger.
Based on the most recent data, BHC has returned 31.19% so far this year. At the same time, Medical stocks have gained an average of 2.48%. As we can see, Bausch Health Cos is performing better than its sector in the calendar year.
Looking more specifically, BHC belongs to the Medical - Generic Drugs industry, a group that includes 23 individual stocks and currently sits at #151 in the Zacks Industry Rank. Stocks in this group have lost about 4.74% so far this year, so BHC is performing better this group in terms of year-to-date returns.
BHC will likely be looking to continue its solid performance, so investors interested in Medical stocks should continue to pay close attention to the company.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Is Bausch Health Cos (BHC) Stock Outpacing Its Medical Peers This Year?
The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Is Bausch Health Cos (BHC - Free Report) one of those stocks right now? By taking a look at the stock's year-to-date performance in comparison to its Medical peers, we might be able to answer that question.
Bausch Health Cos is one of 844 companies in the Medical group. The Medical group currently sits at #3 within the Zacks Sector Rank. The Zacks Sector Rank considers 16 different groups, measuring the average Zacks Rank of the individual stocks within the sector to gauge the strength of each group.
The Zacks Rank is a successful stock-picking model that emphasizes earnings estimates and estimate revisions. The system highlights a number of different stocks that could be poised to outperform the broader market over the next one to three months. BHC is currently sporting a Zacks Rank of #2 (Buy).
Over the past three months, the Zacks Consensus Estimate for BHC's full-year earnings has moved 8.18% higher. This shows that analyst sentiment has improved and the company's earnings outlook is stronger.
Based on the most recent data, BHC has returned 31.19% so far this year. At the same time, Medical stocks have gained an average of 2.48%. As we can see, Bausch Health Cos is performing better than its sector in the calendar year.
Looking more specifically, BHC belongs to the Medical - Generic Drugs industry, a group that includes 23 individual stocks and currently sits at #151 in the Zacks Industry Rank. Stocks in this group have lost about 4.74% so far this year, so BHC is performing better this group in terms of year-to-date returns.
BHC will likely be looking to continue its solid performance, so investors interested in Medical stocks should continue to pay close attention to the company.